Evaluation of Serum Anti-Hbs Concentration in Children Vaccinated with Recombinant Hepatitis B Vaccine at Birth

Evaluation of Serum Anti-Hbs Concentration in Children Vaccinated with Recombinant Hepatitis B Vaccine at Birth

Introduction: Vaccination with the major surface antigen of hepatitis B virus (HBsAg) induces anti-HBs antibody production and level of 10 IU/L is considered protective. It has been shown that the level of anti-HBs antibody does wane after vaccination. The aim of this study was to evaluate the persi...

Full description

Bibliographic Details
Main Authors:	M Nejad-Ghaderi, A Mozafari, J Montazerifar, GH Hassanshahi, HR Rashidi-Nejad, A Jafarzadeh
Format:	Article
Language:	fas
Published:	Shahid Sadoughi University of Medical Sciences 2006-07-01
Series:	Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd
Subjects:	Hepatitis B vaccine Children Anti-HBs antibody
Online Access:	http://jssu.ssu.ac.ir/browse.php?a_id=587&slc_lang=en&sid=1&ftxt=1

Similar Items

"PERSISTENCE OF ANTI-HBs ANTIBODIES IN HEALTHY IRANIAN CHILDREN VACCINATED WITH RECOMBINANT HEPATITIS B VACCINE AND RESPONSE TO A BOOSTER DOSE"
by: A. Jafarzadeh, et al.
Published: (2005-05-01)

"PERSISTENCE OF ANTI-HBs ANTIBODIES IN HEALTHY IRANIAN CHILDREN VACCINATED WITH RECOMBINANT HEPATITIS B VACCINE AND RESPONSE TO A BOOSTER DOSE"
by: A. Jafarzadeh, et al.
Published: (2005-04-01)

Persistence of anti-HBs and immunologic memory in children immunized with hepatitis B vaccine
by: Sharif Md Habibur Rahman, et al.
Published: (2023-06-01)

Protective immunity in a sample of healthy adults following vaccination with a more cost effective recombinant HBsAg vaccine
by: Faseeha Noordeen, et al.
Published: (2022-02-01)

Serum Level of Anti-Hepatitis B Surface Antigen 18 Years after Vaccination in Students of Golestan University of Medical Sciences, Iran
by: Rokhsare Ebneghasem, et al.
Published: (2021-01-01)

Evaluation of serum hepatitis B antibody level in vaccinated children after 14 years in Kashan, Iran
by: Taghavi Ardakani A, et al.
Published: (2012-08-01)

Serum Anti-Hbs-Ag in Stable Hemodialysis Patients and its Relationship with Various Demographic and Biochemical Data
by: Azar BARADARAN, et al.
Published: (2010-12-01)

Original paper Assessment of the level of vaccine-induced anti-HBs antibodies in children with inflammatory systemic connective tissue diseases treated with immunosuppression
by: Izabela Szczygielska, et al.
Published: (2015-05-01)

THE EFFICACY OF HEPATITIS B VACCINE IN HEMOPHILIC PATIENTS WITH HEPATITIS C VIRAL INFECTION
by: H HOUR FAR, et al.
Published: (2003-12-01)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
by: Yan-Wei Zhong, et al.
Published: (2021-12-01)

The Impact of Smoking on Long-Term Protection Following Hepatitis B Vaccination: A 24-Year Cohort Study
by: Marco Fonzo, et al.
Published: (2024-07-01)

COMPARING HEPATITIS B SEROPROTECTION IN PAKISTANI CHILDREN AT 5 AND 6 YEARS OF AGE AFTER EXPANDED PROGRAMME ON IMMUNIZATION (EPI) VACCINATION
by: Ehsan Qadir, et al.
Published: (2020-10-01)

HBsAg in Cord Blood Qf Newborns of HBsAg-Positive Mothers
by: Adnan S. Wiharta, et al.
Published: (2018-11-01)

Hepatitis B vaccine - proposal for a standardized assessment of immune response Vacinação contra Hepatite B - proposta de padronização da avaliação da resposta imunológica
by: Maria Lucia G. Ferraz, et al.
Published: (1992-04-01)

Protection against hepatitis B by the Butang® recombinant vaccine in newborn children in South Brazil
by: Aline Paula Isolani, et al.
Published: (2006-08-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

T-Cell Receptor β Chain and B-Cell Receptor Repertoires in Chronic Hepatitis B Patients with Coexisting HBsAg and Anti-HBs
by: Qiao Zhan, et al.
Published: (2022-06-01)

The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing
by: Ying Wang, et al.
Published: (2021-11-01)

Emerging hepatitis B virus infection in vaccinated populations: a rising concern?
by: Tung-Hung Su, et al.
Published: (2012-07-01)

Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg
by: Yingping Gu, et al.
Published: (2024-02-01)

Clinical implications of HBsAg quantification in patients with chronic hepatitis B
by: Mauro Viganò, et al.
Published: (2012-01-01)

COMPARING HEPATITIS B SEROPROTECTION IN PAKISTANI CHILDREN AT 5 AND 6 YEARS OF AGE AFTER EXPANDED PROGRAMME ON IMMUNIZATION (EPI) VACCINATION
by: Ehsan Qadir, et al.
Published: (2020-10-01)

Hepatitis B vaccination status of health care workers and their antiHBs titres - A cross sectional study
by: Sarwat Fatima, et al.
Published: (2014-07-01)

KONSENTRASI ANTI-HBs PADA KARYAWAN RUMAH SAKIT YANG TELAH MELAKUKAN VAKSINASI HEPATITIS B
by: Doni Setiawan
Published: (2023-06-01)

Serum anti-hepatitis B surface antigen in hemodialysis patients
by: Rafieian-Kopaei Mahmoud, et al.
Published: (2012-01-01)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)

Seromarkers of Hepatitis B virus in newborns with HBsAg positive mothers
by: Yousef Yahyapour (PhD), et al.
Published: (2009-05-01)

Response of Preterm Infants of Mothers Who Are Chronic Carriers of Both HBsAg and HBeAg to Pre-52 Containing Hepatitis 8 Vaccine (TGP 943) - A Preliminary Report
by: Abdul Hamid Sutohardjo
Published: (2018-10-01)

Evaluation of Chronic Hepatitis B Infection in Patients with Seronegative HbsAg
by: E Gholami Parizad, et al.
Published: (2012-02-01)

Evaluation of Chronic Hepatitis B Infection in Patients With Seronegative HbsAg
by: N Sadeghifard, et al.
Published: (2012-02-01)

Acute hepatitis B in pregnancy with surprisingly rapid clearance of serum HBs antigen associated with a favourable outcome
by: Steven Roger, et al.
Published: (2022-05-01)

Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function
by: Yisi Liu, et al.
Published: (2024-03-01)

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
by: Luisa Roade, et al.
Published: (2023-10-01)

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon
by: Hong Li, et al.
Published: (2022-12-01)

Active-passive Immunization Effectiveness Against Hepatitis B Virus in Children Born to HBsAg Positive Mothers in Amol, North of Iran
Published: (2011-11-01)

The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines
by: Inna Tulaeva, et al.
Published: (2024-09-01)

Accuracy Validation of the Elecsys HBsAg II Quant Assay and Its Utility in Resolving Equivocal Qualitative HBsAg Results
by: Jaehyeon Lee, et al.
Published: (2023-02-01)

Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012–2013
by: Rashid Ansumana, et al.
Published: (2018-02-01)

Commentary: Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
by: Maria Pfefferkorn, et al.
Published: (2022-12-01)

Evaluating the Immunity against Hepatitis B Virus and Frequency of HBsAg Positive Cases among Medical Staff of Shahid Beheshti Hospital in Yasuj, 2016
by: MT Rezanejad, et al.
Published: (2017-12-01)